A clinical trial for comparison between combination of dyes to identify first draining lymph nodes in patients of Breast Cancer
Phase 3
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2020/02/023503
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Upfront operable primary breast tumor measuring upto and including 5cm in maximum tumor dimension with clinically lymph node negative breast cancers (Tis, T1,T2-N0)
2. Consenting patient
Exclusion Criteria
1.With T3, T4 lesions
2.Who are Pregnant, Lactating
3.Patients with history of previous radiotherapy to the breast or axilla
4.Patients with history of previous surgery of Axilla or chest wall
5.Patients who have received Neo-adjuvant chemotherapy
6.H/o hypersensitivity to any of the agents used
7.Not giving consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Detection proportion among both groups-Proportion of number of sentinel lymph nodes identified in each group <br/ ><br>Timepoint: 25/01/2020 to 30/11/2021
- Secondary Outcome Measures
Name Time Method - Cost calculation and procedure time of doing SLNB in each groupTimepoint: 25/01/2020 to 30/11/2021